Search
for
Sort by
Research 151–180 of 1000+
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Insulin-like growth factor-1: roles in androgenetic alopecia
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Deletion of adipocyte Sine Oculis Homeobox Homolog 1 prevents lipolysis and attenuates skin fibrosis
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Follow-Up of 1 mg Finasteride Treatment of Male Pattern Baldness—Difference between Clinical Trials and Private Office Follow-Up
- Insulin Promotes Corneal Nerve Repair and Wound Healing in Type 1 Diabetic Mice by Enhancing Wnt/β-Catenin Signaling
- Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis
- A Practitioner's Guide to Hair Loss Part 1—History, Biology, Genetics, Prevention, Conventional Treatments, and Herbals
- Inhibition of Insulin-Like Growth Factor-1–Induced Sebum Production by Bilobetin in Cultured Human Sebocytes
- Comparative Efficacy of Topical Tacrolimus 0.1% and Clobetasol Propionate 0.05% in the Treatment of Alopecia Areata (AA)
- Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
- Volumes 2 and 3: The Head and Neck (Parts 1 and 2)
- Decline of life’s energy theory of ageing 1. Revitalisation of energy metabolism and ageing mitochondria
- Preparation and Physicochemical Evaluation of Topical Cream Ivermectin 1% for Treatment of Rosacea
- AGD1, a class 1 ARF‐GAP, acts in common signaling pathways with phosphoinositide metabolism and the actin cytoskeleton in controlling Arabidopsis root hair polarity
- Immunoregulatory mechanisms and stress hormones in psoriasis (part 1)
- Botanicals With Dermatologic Properties Derived From First Nations Healing: Part 1—Trees
- Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): Three- and 4-year results
- A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
- Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”
- A trial of 1% minoxidil used topically for severe alopecia areata.
- The clinical spectrum of parathyroid disease
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Investigation on antimicrobial, antioxidant, and anti-cancerous activity of Agaricus bisporus derived β-Glucan against cervical cancer cell line
- Real‐World Clinical Outcomes With a 1% SeleniumSulfide/1% Salicylic Acid Shampoo Formulation for Seborrheic Dermatitis and Dandruff: A Multicenter Observational Study
- Tuning Scaffold Properties of New 1,4-Substituted Pyrrolo[3,2-c]quinoline Derivatives Endowed with Anticancer Potential, New Biological and In Silico Insights
- Special Forms of Hair Transplantation
- Differences in cell subsets between sun-exposed and unexposed skin: preliminary single-cell sequencing and biological analysis from a single case
- Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment